Company intelligence / Profile preview

Atome Pharma Group

Ownership: Private
Employees: ~50
Development stage: Commercial

Overview

Atome Pharma Group is an active pharmaceutical service provider focused on improving access to quality health services in emerging markets, particularly across Africa and the UAE. The company offers regulatory affairs, market access support, marketing and sales training, logistics support, institutional market services, and pharmacovigilance. It acts as a partner for both public and private sector clients seeking to launch or expand healthcare projects in regions with limited access to medicines and medical supplies[1][5][6].

Therapeutic areas: Other
Modalities: Not specified; company is a service provider, not a drug developer[1][6].
Industry: Consulting

Drug pipeline

1 asset

tafenoquine

Commercial

Indications: Plasmodium vivax malaria

Partnerships

Collaborates with institutions and partners for project launches in emerging markets.(No specific major pharma/biotech partnerships named)[1][5].

Beyond the preview

Go deeper on Atome Pharma Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Atome Pharma Group.

Explore the full profile